[Pharmacodynamics of 5-(1,3,3-trimethylindolinyl)N,N-dimethyl carbamate in mice].
D000818:Animals; D001921:Brain / Q000378:metabolism; D002219:Carbamates / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000097:blood / Q000378:metabolism*; D005260:Female; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008916:Miotics / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D007211:Indoles; D008916:Miotics; C052554:N,N-dimethylcarbamic acid 2,3-dihydro-1,3,3-trimethylindol-5-yl ester; D002802:Cholinesterases